Log in to search using one of your social media accounts:

 

Prostate cancer now kills more people than breast cancer, UK figures reveal

Male illness now third most common cause of cancer death behind lung and bowelProstate cancer has become the third most common cause of cancer death in the UK, overtaking breast cancer, despite improvements in survival rates for both.The top cancer killer in the UK is lung cancer, which claimed 35,486 lives in 2015, followed by colorectal cancer, with a toll of 16,067 people.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Prostate cancer Cancer research Science UK news Health Medical research Society Source Type: news

Related Links:

Authors: Wang Y, Lan GB, Peng FH, Xie XB Abstract Renal transplantation is associated with an increased risk of cancers at multiple sites; however, the relationships between increased cancer risk and participant characteristics remain unclear. We searched PubMed, Embase, and the Cochrane Library to identify prospective observational studies performed up to July 2017. Totally 11 prospective studies reported data on 79,988 renal transplant recipients were included. Renal transplant recipients were found to display a higher risk of all cancers (standard incidence ratio [SIR]: 2.89; 95% CI: 2.13-3.91; P
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
In battle, the standard-bearer honorarily carries the flag, which represents the nobility and purpose of continuing the fight. In the war on cancer many advances have been made that surround the more common cancers such as breast cancer, prostate cancer, colon cancer, and lung cancer. However, there are these rare tumors of mesenchymal origin, sarcomas, which have disproportionately advanced the front lines of our understanding of cancer mechanisms. It is because of sarcoma research that we even know what oncogenes and tumor suppressor genes are.
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Source Type: research
In battle, the standard-bearer honorarily carries the flag, which represents the nobility and purpose of continuing the fight. In the war on cancer many advances have been made that surround the more common cancers such as breast cancer, prostate cancer, colon cancer, and lung cancer. However, there are these rare tumors of mesenchymal origin, sarcomas, which have disproportionately advanced the front lines of our understanding of cancer mechanisms. It is because of sarcoma research that we even know what oncogenes and tumor suppressor genes are.
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Source Type: research
Authors: Peng X, Shi J, Sun W, Ruan X, Guo Y, Zhao L, Wang J, Li B Abstract IL-6 is critical for tumorigenesis. However, previous studies on the association of IL-6 promoter polymorphisms with predisposition to different cancer types are somewhat contradictory. Therefore, we performed this meta-analysis regarding the relationship between IL-6 promoter single nucleotide polymorphisms and cancer susceptibility and prognosis. Up to April 2017, 97 original publications were identified covering three IL-6 promoter SNPs. Our results showed statistically significant association between IL-6 promoter and cancer risk and pr...
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
Conclusions -Lower limb arterial thrombosis was a marker of occult cancer, especially lung cancer, and was an adverse prognostic factor for mortality in common cancers. PMID: 29540440 [PubMed - as supplied by publisher]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Circulation Source Type: research
AbstractBackgroundThe EDIFICE surveys have assessed cancer screening behavior in the French population since 2005.MethodsThe 2016 edition was conducted among a representative sample of 1501 individuals (age, 50 –75 years). The current analysis focuses on breast, colorectal, prostate, lung, and cervical cancer screening.ResultsThe rate of women (50 to 74  years) declaring having had at least one breast cancer screening test in their lifetime remained stable and high between 2005 and 2016. Compliance with recommended screening intervals improved between 2005 and 2011 from 75 to 83%, respectively, then decreas...
Source: Current Oncology Reports - Category: Cancer & Oncology Source Type: research
Publication date: 25 March 2018 Source:International Journal of Pharmaceutics, Volume 539, Issues 1–2 Author(s): Arivalagan Pugazhendhi, Thomas Nesakumar Jebakumar Immanuel Edison, Indira Karuppusamy, Brindhadevi Kathirvel Cancer is an abnormal condition leading to uncontrolled cell division which causes damage to the body tissues. Around 100 types of cancer are studied so far namely breast cancer, lung cancer, skin cancer, prostate cancer, colon cancer and lymphoma. Major cancer therapies include chemotherapy, surgery and radiations but their major drawbacks are non-specifically distributed antitumor agents, uneven...
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
CONCLUSIONS: Since the onset of the economic crisis in Spain the rate of decline in cancer mortality has slowed significantly, and this situation could be exacerbated by the current austerity measures in healthcare. PMID: 29452751 [PubMed - as supplied by publisher]
Source: Gaceta Sanitaria - Category: International Medicine & Public Health Tags: Gac Sanit Source Type: research
By BISHAL GYAWALI, MD Why conduct post approval studies at all? Atezolizumab previously received accelerated approval in second-line metastatic or advanced urothelial cancer based on response rates from a single arm trial. The results of post approval confirmatory phase 3 are now published and demonstrate that atezolizumab did not improve survival versus chemotherapy (11.1 v 10.6 months, HR 0.87, p = 0.41). The concept of accelerated approval is to grant early and conditional approval and access to drugs in diseases of unmet need, and that the decision to fully approve or revoke be made based ...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Source Type: blogs
Abstract Chemical investigation of Vicia monantha subsp. monantha Retz. revealed isolation of one new hydroxy- fatty acid (6) identified as (6-Z, 10-E)-9-hydroxy henicosa-6,10-dienoic acid in addition to six known metabolites; hexadecanoic acid (1), β-sitosterol (2), β-amyrin (3), β-sitosterol-glucoside (4), 2,3-dihydroxypropyl tetradecanoate (5) and (Z)-9-hydroxypentadec-6-enoic acid (7). The cytotoxic effect of the isolated compounds was assessed by MTT assay using lung cancer A-549, prostate cancer PC3, breast cancer MCF-7, colon cancer HCT-116 and liver cancer HepG2 cell lines. On...
Source: Natural Product Research - Category: Biochemistry Authors: Tags: Nat Prod Res Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | Lung Cancer | Prostate Cancer | Research | Science